30^th European Nephrology Conference

About the Conference

Sessions and Tracks

Track 1: Chronic Kidney Disease (CKD) – Early Detection & Prevention

This track focuses on the growing global burden of chronic kidney disease (CKD) and emphasizes the critical importance of early diagnosis and prevention strategies. Sessions will explore major CKD risk factors, including diabetes, hypertension, aging, obesity, and lifestyle influences, while highlighting population-specific vulnerabilities. Experts will discuss effective screening programs, CKD staging, and the use of biomarkers and imaging techniques for early detection and monitoring of disease progression. Preventive nephrology will be a central theme, covering dietary interventions, physical activity, patient education, and community-based health programs designed to reduce the incidence and complications of CKD. Innovative approaches, including technology-driven monitoring, telemedicine, and multidisciplinary care models, will be presented. The track will also address health policy, population-level prevention strategies, and disparities in access to care, aiming to promote equitable kidney health. It is ideal for clinicians, researchers, and public health professionals seeking to improve early intervention and long-term outcomes for patients worldwide.

Track 2: Acute Kidney Injury (AKI) & Critical Care Nephrology

This track addresses acute kidney injury (AKI) as a major challenge in hospitalized and critically ill patients. Sessions will cover AKI pathophysiology, early diagnosis, and management in intensive care settings. Key topics include sepsis-related AKI, drug-induced nephrotoxicity, surgical complications, and contrast-associated kidney injury. Experts will discuss renal replacement therapy in critical care, fluid management, and hemodynamic monitoring. The track also explores recovery after AKI, long-term outcomes, and prevention strategies. Case-based discussions and clinical guidelines will help translate evidence into practice.In addition, the track will highlight emerging biomarkers, point-of-care testing, and innovative technologies that support early detection and personalized treatment plans. Multidisciplinary approaches involving nephrologists, intensivists, pharmacists, and nursing teams will be emphasized to optimize patient care. Sessions will also address strategies for patient education, risk reduction, and post-discharge follow-up, ensuring better long-term kidney function and overall outcomes. This track is highly relevant for all professionals managing critically ill patients with kidney injury.

Track 3: Dialysis Technologies & Renal Replacement Therapy

This track focuses on the latest advancements in dialysis and renal replacement therapies for patients with end-stage kidney disease. Sessions will cover innovations in hemodialysis and peritoneal dialysis, including strategies to optimize dialysis adequacy, manage vascular access, and prevent infections. The track will also explore emerging technologies such as home dialysis programs, portable and wearable dialysis devices, and individualized dialysis prescriptions designed to improve patient comfort and treatment outcomes.Patient-centered care will be emphasized, with discussions on quality of life, shared decision-making, and strategies to reduce the physical and emotional burden of dialysis. Sessions will highlight best practices for monitoring, troubleshooting complications, and implementing evidence-based protocols in clinical practice. Researchers and industry experts will present novel approaches that enhance safety, efficiency, and effectiveness of dialysis therapies, providing valuable insights for nephrologists, nurses, technicians, and healthcare professionals dedicated to improving renal care.

Track 4: Kidney Transplantation & Transplant Immunology

This track provides a comprehensive overview of kidney transplantation, covering the full journey from donor selection to long-term graft survival. Sessions will focus on transplant immunology, mechanisms of acute and chronic rejection, and advances in immunosuppressive therapies aimed at improving graft longevity while minimizing adverse effects. Tolerance strategies and individualized immunosuppression protocols will also be explored. Key topics include organ preservation techniques, living and deceased donor transplantation, and optimization of transplant outcomes. Discussions will address post-transplant complications such as infections, malignancy, cardiovascular risk, and metabolic disorders. Ethical considerations, equitable access to transplantation, and strategies to expand the donor pool will be highlighted.The track will also showcase advances in graft monitoring, including biomarkers, imaging, and immune surveillance tools for early detection of rejection. Designed for transplant nephrologists, surgeons, researchers, and transplant coordinators, this track supports evidence-based practices and innovation in transplant care.

Track 5: Hypertension & Cardio-Renal Syndrome

This track explores the strong and complex relationship between kidney disease and cardiovascular health. Sessions will focus on the management of hypertension in chronic kidney disease, including resistant hypertension, optimal blood pressure targets, and individualized treatment strategies. Current guidelines, clinical trials, and emerging evidence will be discussed to support best practices in hypertension control.The concept of cardio-renal syndrome will be examined in depth, highlighting the bidirectional interactions between heart failure and kidney dysfunction. Key topics include vascular and endothelial dysfunction, volume overload, vascular access complications, and strategies to reduce cardiovascular risk in patients with kidney disease. Practical approaches to managing comorbid cardiac and renal conditions in clinical settings will be emphasized.By integrating cardiology and nephrology perspectives, this track supports collaborative care models that improve patient outcomes. It is designed for nephrologists, cardiologists, and internal medicine specialists seeking evidence-based, real-world solutions for complex cardio-renal conditions.

Track 6: Diabetic Kidney Disease & Metabolic Disorders

This track focuses on diabetic kidney disease and metabolic conditions that significantly impact renal health worldwide. Sessions will explore the pathophysiology of diabetic nephropathy, early detection strategies, risk stratification, and factors influencing disease progression. Emphasis will be placed on timely intervention to prevent complications and slow the decline of kidney function. Key discussions will highlight emerging and established therapies, including SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists, along with their clinical benefits and real-world applications. The track will also address obesity-related kidney disease, insulin resistance, metabolic syndrome, and their interconnections with cardiovascular risk. Lifestyle modification, optimal glycemic control, blood pressure management, and patient education will be central themes. Multidisciplinary care models involving nephrologists, endocrinologists, dietitians, and primary care providers will be emphasized to improve outcomes. This track supports integrated, evidence-based strategies for managing metabolic kidney disease.

Track 7: Glomerular Diseases & Autoimmune Nephrology

This track focuses on immune-mediated and glomerular kidney diseases that present complex diagnostic and therapeutic challenges. Sessions will cover major conditions such as glomerulonephritis, lupus nephritis, vasculitis, IgA nephropathy, and nephrotic syndrome across different age groups. Experts will discuss advances in disease classification, risk stratification, and early diagnosis using renal biopsy techniques, serological markers, and emerging biomarkers. Treatment-focused sessions will highlight current and evolving therapeutic strategies, including immunosuppressive regimens, biologic agents, and personalized medicine approaches aimed at improving efficacy while minimizing toxicity. The track will also address disease monitoring, management of relapses, and strategies to prevent long-term complications such as chronic kidney disease and cardiovascular risk. By integrating clinical evidence, translational research, and real-world practice, this track provides valuable insights for clinicians and researchers dedicated to improving outcomes in patients with complex autoimmune and glomerular kidney disorders.

Track 8: Precision Medicine & Genetic Kidney Disorders

This track explores the growing role of genomics and precision medicine in modern nephrology. Sessions will focus on inherited kidney diseases, rare and orphan renal disorders, and the expanding use of genetic testing in clinical practice. Key topics include molecular diagnostics, next-generation sequencing, genotype–phenotype correlations, and the identification of disease-causing variants that influence kidney function and progression.The track will highlight how personalized medicine enables more accurate diagnosis, tailored treatment selection, and improved prognostic assessment. Emerging targeted therapies, gene-based interventions, and novel clinical trials will be discussed, along with their translational impact on patient care. Ethical considerations, data privacy, and the importance of genetic counseling for patients and families will also be addressed.By bridging research and clinical practice, this track supports future-focused nephrology care and provides valuable insights for clinicians, researchers, and genetic specialists seeking to integrate precision medicine into kidney disease management.

Track 9: Biomarkers, Imaging & Diagnostics in Nephrology

This track focuses on advancing the diagnosis, monitoring, and management of kidney diseases through cutting-edge biomarkers and imaging technologies. Sessions will cover novel renal biomarkers for early detection, risk stratification, and treatment response assessment, alongside non-invasive diagnostic tools that enhance patient safety and comfort. Innovations in imaging techniques, including advanced ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and nuclear imaging, will be explored for their role in improving accuracy, monitoring disease progression, and guiding clinical decisions. The track will also highlight integration of diagnostic data with electronic health records and predictive analytics to support personalized patient care. Emphasis will be placed on translating research into clinical practice, improving diagnostic efficiency, and enabling timely interventions. This track is ideal for nephrologists, radiologists, researchers, and healthcare professionals interested in leveraging biomarkers and imaging to enhance outcomes and advance precision nephrology.

Track 10: Artificial Intelligence & Digital Nephrology

This track explores the transformative role of digital technologies and artificial intelligence (AI) in modern kidney care. Sessions will cover AI-driven diagnostics, predictive analytics, machine learning models, and their applications in identifying kidney disease early and predicting disease progression. Emerging topics such as tele-nephrology, remote patient monitoring, mobile health applications, and integration with electronic health records will also be discussed, emphasizing their potential to enhance clinical decision-making and streamline care delivery.The track will highlight how digital tools can improve patient engagement, treatment adherence, and overall outcomes while reducing healthcare costs and clinical burden. Ethical considerations, data privacy, cybersecurity, and responsible AI implementation will be key points of discussion to ensure safe and equitable use. This track is designed for clinicians, researchers, health technology developers, and policy makers seeking insights into cutting-edge digital solutions that are reshaping nephrology practice.

Track 11: Pediatric Nephrology & Congenital Kidney Diseases

This track focuses on kidney diseases affecting children and adolescents, with emphasis on early diagnosis and long-term kidney health. Sessions will cover congenital anomalies of the kidney and urinary tract (CAKUT), pediatric chronic kidney disease (CKD), inherited and rare renal disorders, and growth-related complications. Experts will discuss advances in prenatal screening, genetic testing, and pediatric biomarkers that support early intervention and improved outcomes.Key topics include pediatric dialysis modalities, kidney transplantation, immunosuppressive management, and prevention of disease progression in young patients. Special attention will be given to nutritional management, growth and development, and psychosocial support for children and their families. The track also highlights family-centered and multidisciplinary care approaches.A dedicated focus will be placed on the transition from pediatric to adult nephrology care, addressing continuity of treatment and long-term follow-up. This track aims to improve lifelong kidney health through integrated, age-appropriate, and compassionate nephrology care.

Track 12: Geriatric Nephrology & Aging Kidneys

This track focuses on kidney disease in older adults, addressing the unique clinical and ethical challenges of aging kidneys. Sessions will explore age-related decline in renal function, physiological changes, and the impact of frailty on diagnosis and treatment decisions. Special attention will be given to polypharmacy, drug dosing, and the prevention of medication-related kidney injury in elderly patients. Key topics include management of chronic kidney disease in older populations, comorbid conditions, and individualized treatment strategies that balance clinical benefit with patient comfort. Discussions will also highlight conservative and supportive care approaches, shared decision-making, and end-of-life planning in advanced kidney disease. Quality of life, functional status, and patient preferences will be central themes throughout this track.By integrating clinical expertise with compassionate care, this track supports patient-centered nephrology practices that promote dignity, safety, and improved outcomes for aging populations.

Track 13: Renal Nutrition, Lifestyle & Preventive Care

This track highlights the essential role of nutrition and lifestyle in maintaining kidney health and managing kidney disease across all stages. Sessions will focus on evidence-based renal nutrition, including individualized renal diets, protein intake management, electrolyte balance, fluid regulation, and micronutrient considerations in chronic kidney disease, dialysis, and post-transplant care. Experts will discuss dietary strategies to slow disease progression, manage complications, and improve metabolic outcomes.Lifestyle interventions such as physical activity, weight management, smoking cessation, and stress reduction will be emphasized as key components of preventive nephrology. The track will also explore patient education, counseling techniques, and culturally sensitive dietary planning to improve adherence and long-term outcomes. Special attention will be given to interdisciplinary collaboration between nephrologists, dietitians, nurses, and primary care providers.By integrating nutrition science with lifestyle medicine, this track supports a holistic, patient-centered approach to kidney care that enhances quality of life, empowers patients, and promotes sustainable kidney health.

Track 14: Public Health, Epidemiology & Global Kidney Care

This track focuses on kidney health from a population and global perspective, addressing the rising burden of kidney disease worldwide. Sessions will explore epidemiology, surveillance data, and trends in chronic and acute kidney diseases across different regions and populations. Key topics include social determinants of health, environmental factors, and health system challenges that influence kidney disease prevention, diagnosis, and treatment.Discussions will highlight disparities in access to kidney care, dialysis, and transplantation, particularly in low- and middle-income countries. Policy development, health economics, and resource allocation strategies will be examined to improve equitable kidney care delivery. The track will also emphasize community-based prevention programs, public awareness initiatives, and early screening models. By encouraging international collaboration and knowledge exchange, this track aims to strengthen global kidney health strategies, support sustainable healthcare systems, and reduce the worldwide impact of kidney disease through coordinated public health action.

Track 15: Patient-Centered Care, Quality of Life & Ethics

This track focuses on placing patients at the center of kidney care by addressing quality of life, ethical decision-making, and compassionate clinical practice. Sessions will explore shared decision-making models that respect patient values, preferences, and cultural backgrounds throughout the course of kidney disease. Mental health support, including the management of anxiety, depression, and treatment-related stress, will be a key focus.The track will highlight palliative and supportive nephrology care, symptom management, and end-of-life planning for patients with advanced kidney disease. Ethical challenges such as treatment choices, dialysis withdrawal, informed consent, and equitable access to care will be discussed through real-world case studies. Communication skills and multidisciplinary approaches will be emphasized to enhance patient trust and engagement.By integrating ethics, empathy, and holistic care, this track aims to improve patient satisfaction, dignity, and overall well-being while supporting healthcare professionals in delivering compassionate, ethically sound nephrology care.

Market Analysis

The global nephrology drugs market is experiencing significant growth and is estimated to be valued at USD 17.2 billion in 2024, projected to reach USD 26.9 billion by 2031, growing at a CAGR of 6.6%. This growth is fueled by the rising prevalence of kidney-related disorders such as chronic kidney disease (CKD), acute kidney injury (AKI), diabetes-associated nephropathy, polycystic kidney disease, and other renal complications. According to the World Health Organization (WHO), approximately 10% of the world’s population was affected by CKD in 2020, with acute kidney injury impacting over 13 million people annually, highlighting the global urgency of kidney health management.

Major risk factors driving this trend include aging populations, increasing prevalence of diabetes and hypertension, rising obesity rates, and environmental pollutants, which collectively contribute to both chronic and end-stage kidney diseases. Consequently, the demand for dialysis, kidney transplantation, and innovative nephrology drugs has surged, attracting significant investment from pharmaceutical companies developing novel therapies for both acute and chronic kidney conditions.The growing geriatric population and increased public awareness of kidney health are further boosting the market, emphasizing the importance of early diagnosis, preventive strategies, and access to effective treatments. However, challenges such as stringent regulatory requirements, high R&D costs, and long clinical trial timelines continue to shape the industry. Developing a new drug can cost USD 250–350 million, with only a small fraction of candidates successfully gaining approval.

Key Associations and Societies for Nephrology:

• American Society of Nephrology (ASN)
• European Renal Association – European Dialysis and Transplant Association (ERA-EDTA)
• National Kidney Foundation (NKF)
• Asian Pacific Society of Nephrology (APSN)
• Latin American Society of Nephrology and Hypertension (SLANH)
• Renal Physicians Association (RPA)
• Canadian Society of Nephrology (CSN)
• Indian Society of Nephrology (ISN)
• Australian and New Zealand Society of Nephrology (ANZSN)
• African Association of Nephrology (AFRAN)
• Japanese Society of Nephrology (JSN)
• Chinese Society of Nephrology (CSN)
• Middle East Society of Nephrology and Transplantation (MESNT)
• Society of Nephrology Nurses and Technicians (SNNT)
  
  Participation Benefits:

• Participants will receive an official Certificate of Participation.
• Dedicated speaker pages will be created on the conference website for all invited presenters.
• Extensive networking opportunities with global leaders, renowned nephrologists, and industry experts.
• 2-day complimentary breakfast, lunch, and refreshments provided during the conference.
• Young Researcher Awards and Best Poster Awards to recognize and encourage emerging talent in nephrology research.
• All submitted abstracts will be published in high-impact, peer-reviewed journals with a unique DOI number, ensuring global visibility.
• Your clinic or organization’s name and logo will be featured in the conference proceedings book and prominently on the conference website, offering excellent exposure.
• Opportunities for collaboration, partnerships, and sponsorships with leading organizations in nephrology.
  
  The 30th European Nephrology Conference in Berlin presents a unique platform for nephrologists, clinicians, researchers, and industry leaders to share insights, explore innovative therapies, and collaborate on cutting-edge solutions. With kidney disease prevalence escalating worldwide, this conference offers timely knowledge exchange on diagnostics, treatment strategies, precision medicine, and emerging technologies, making it a must-attend event for professionals seeking to shape the future of renal care and improve patient outcomes globally.